Jieyu G. Qi

No. 6666 Furong Road, Changqing District
Jinan, 250307, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Correction to: Knockdown of Foxg1 in supporting cells increases the trans‑differentiation of supporting cells into hair cells in the neonatal mouse cochlea.

Correction to: Knockdown of Foxg1 in supporting cells increases the trans‑differentiation of supporting cells into hair cells in the neonatal mouse cochlea.

Journal: Cellular and molecular life sciences : CMLS

Published: July 17, 2026

Efficient and Safe Transduction of Cochlear Outer Hair Cells in Adult Mice with AAV2.7m8-Myo15.

Efficient and Safe Transduction of Cochlear Outer Hair Cells in Adult Mice with AAV2.7m8-Myo15.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: January 31, 2026

Gene Editing Technologies for Hereditary Hearing Loss: Prospects and Challenges.

Gene Editing Technologies for Hereditary Hearing Loss: Prospects and Challenges.

Journal: Neuroscience bulletin

Published: January 06, 2026

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Recent advancements in improving cross-species applicability of bioengineered AAV capsids.

Journal: Gene therapy

Published: December 10, 2025

Human promoter-driven AAV tools enable precision gene therapy targeting cochlear hair cells.

Human promoter-driven AAV tools enable precision gene therapy targeting cochlear hair cells.

Journal: Cell reports. Medicine

Published: October 03, 2025

Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies.

Dysregulation of Serpinb6a-Gch1 axis contributes to DFNB91 deafness that is amendable to gene therapies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: September 14, 2025

International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials.

International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials.

Journal: Med (New York, N.Y.)

Published: July 22, 2025

Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model.

Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model.

Journal: Med (New York, N.Y.)

Published: July 18, 2025

Establishment of a Cochlear Organoid Platform for Remodeling the Extracellular Matrix.

Establishment of a Cochlear Organoid Platform for Remodeling the Extracellular Matrix.

Journal: ACS nano

Published: July 15, 2025

Author Correction: mRNA metabolism regulator human antigen R (HuR) regulates age-related hearing loss in aged mice.

Author Correction: mRNA metabolism regulator human antigen R (HuR) regulates age-related hearing loss in aged mice.

Journal: Nature aging

Published: July 08, 2025

Treating Hearing Loss: From Cochlear Implantation to Gene Therapy.

Treating Hearing Loss: From Cochlear Implantation to Gene Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: May 30, 2025

OTOF-related gene therapy: a new way but a long road ahead.

OTOF-related gene therapy: a new way but a long road ahead.

Journal: Lancet (London, England)

Published: February 03, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026